Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VTI, BN, Tempus Ai, ASML, CRM, and represent 45.36% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 10 stocks: VTI (+$278M), Tempus Ai (+$143M), EWTX (+$114M), MRUS (+$40M), CLDX (+$32M), MORF (+$13M), VRDN (+$12M), PHVS (+$11M), PCVX (+$7.9M), KYTX (+$7.9M).
- Started 6 new stock positions in CLDX, Tempus Ai, VTI, MORF, MRUS, EWTX.
- Reduced shares in these 9 stocks: EPC (-$116M), ASML (-$50M), INSM (-$36M), BPMC (-$20M), INSP (-$14M), TMCI, CRNX, LXEO, IOBT.
- Sold out of its positions in EPC, INSP, TMCI.
- Novo Holdings A/S was a net buyer of stock by $427M.
- Novo Holdings A/S has $1.9B in assets under management (AUM), dropping by 27.95%.
- Central Index Key (CIK): 0001388325
Tip: Access up to 7 years of quarterly data
Positions held by Novo A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 38 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 15.0 | $278M | NEW | 1.0M | 267.51 |
|
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 8.7 | $161M | 3.9M | 41.54 |
|
|
| Tempus Ai Cl A | 7.7 | $143M | NEW | 4.1M | 35.00 |
|
| Asml Holding N V N Y Registry Shs (ASML) | 7.4 | $136M | -26% | 133k | 1022.73 |
|
| salesforce (CRM) | 6.7 | $123M | 480k | 257.10 |
|
|
| Edgewise Therapeutics (EWTX) | 6.2 | $114M | NEW | 6.3M | 18.01 |
|
| Corcept Therapeutics Incorporated (CORT) | 4.2 | $78M | 2.4M | 32.49 |
|
|
| Vaxcyte (PCVX) | 3.9 | $72M | +12% | 950k | 75.51 |
|
| Insmed Com Par $.01 (INSM) | 2.9 | $54M | -40% | 800k | 67.00 |
|
| Mirum Pharmaceuticals (MIRM) | 2.8 | $51M | 1.5M | 34.19 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $45M | -8% | 1.0M | 44.79 |
|
| Cable One (CABO) | 2.3 | $42M | 118k | 354.00 |
|
|
| BioMarin Pharmaceutical (BMRN) | 2.2 | $40M | +8% | 490k | 82.33 |
|
| Merus N V (MRUS) | 2.2 | $40M | NEW | 675k | 59.17 |
|
| Apple (AAPL) | 2.1 | $39M | 183k | 210.62 |
|
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 1.9 | $36M | 501k | 72.00 |
|
|
| Pharvaris N V (PHVS) | 1.7 | $32M | +47% | 1.7M | 18.80 |
|
| Celldex Therapeutics Com New (CLDX) | 1.7 | $32M | NEW | 850k | 37.01 |
|
| 4d Molecular Therapeutics In (FDMT) | 1.6 | $29M | 1.4M | 20.99 |
|
|
| Lanzatech Global (LNZA) | 1.6 | $29M | 16M | 1.85 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $29M | 118k | 243.00 |
|
|
| Arrivent Biopharma (AVBP) | 1.5 | $28M | +39% | 1.5M | 18.55 |
|
| Miragen Therapeutics (VRDN) | 1.4 | $26M | +81% | 2.0M | 13.01 |
|
| Cargo Therapeutics (CRGX) | 1.4 | $25M | +23% | 1.5M | 16.42 |
|
| Amicus Therapeutics (FOLD) | 1.3 | $25M | 2.5M | 9.92 |
|
|
| Brookfield Asset Managmt Cl A Lmt Vtg Shs (BAM) | 1.3 | $24M | 627k | 38.05 |
|
|
| Rocket Pharmaceuticals (RCKT) | 1.3 | $24M | +4% | 1.1M | 21.53 |
|
| Lexeo Therapeutics (LXEO) | 1.3 | $23M | -11% | 1.5M | 16.04 |
|
| Blueprint Medicines (BPMC) | 1.0 | $19M | -51% | 175k | 107.78 |
|
| Kyverna Therapeutics (KYTX) | 0.7 | $13M | +150% | 1.8M | 7.50 |
|
| Morphic Hldg (MORF) | 0.7 | $13M | NEW | 375k | 34.07 |
|
| Verve Therapeutics (VERV) | 0.6 | $12M | +20% | 2.4M | 4.88 |
|
| Metagenomi (MGX) | 0.4 | $7.3M | +3% | 1.8M | 4.08 |
|
| Io Biotech (IOBT) | 0.3 | $5.2M | -12% | 4.4M | 1.17 |
|
| Abcellera Biologics (ABCL) | 0.2 | $3.3M | 1.1M | 2.96 |
|
|
| Marqeta Class A Com (MQ) | 0.1 | $2.4M | 442k | 5.48 |
|
|
| Galecto (GLTO) | 0.1 | $1.2M | 2.5M | 0.47 |
|
|
| Spero Therapeutics (SPRO) | 0.0 | $610k | 469k | 1.30 |
|
Past Filings by Novo Holdings A/S
SEC 13F filings are viewable for Novo Holdings A/S going back to 2014
- Novo Holdings A/S 2024 Q2 restated filed Aug. 20, 2024
- Novo Holdings A/S 2024 Q1 filed May 15, 2024
- Novo Holdings A/S 2023 Q4 filed Feb. 14, 2024
- Novo Holdings A/S 2023 Q3 filed Nov. 14, 2023
- Novo Holdings A/S 2023 Q2 filed Aug. 14, 2023
- Novo Holdings A/S 2023 Q1 filed May 15, 2023
- Novo Holdings A/S 2022 Q4 filed Feb. 14, 2023
- Novo Holdings A/S 2022 Q3 filed Nov. 14, 2022
- Novo Holdings A/S 2022 Q2 filed Aug. 15, 2022
- Novo Holdings A/S 2022 Q1 restated filed May 27, 2022
- Novo Holdings A/S 2022 Q1 filed May 16, 2022
- Novo Holdings A/S 2021 Q4 filed Feb. 14, 2022
- Novo Holdings A/S 2021 Q3 filed Nov. 15, 2021
- Novo Holdings A/S 2021 Q2 filed Aug. 16, 2021
- Novo Holdings A/S 2021 Q1 filed May 17, 2021
- Novo Holdings A/S 2020 Q4 filed Feb. 16, 2021